Abstract
B-cell non-Hodgkin’s lymphomas (NHL) can be associated with amyloidogenic immunoglobulin chain and non-amyloidogenic immunoglobulin chain disease. In both groups of disorders, the hepatobiliary tract can be involved in form of various patterns. Hepatic amyloidosis caused by NHL is termed amyloid light-chain or AL amyloidosis (primary amyloidosis) and develops in the setting of various B-cell neoplasms, most commonly with plasmacytoma. This form of amyloidosis induces an enlarged liver with increased transparency and elevated consistency. The predominant histological localization of amyloid is perisinusoidal and in portal tracts, associated with marked atrophy of hepatocyte plates. In a minority of cases of AL amyloidosis, tumor-like amyloid masses can develop (amyloidoma or amyloid tumor). This tumefactive hepatic amyloidosis is a very rare disorder. Amyloidosis can rarely involve intrahepatic and extrahepatic bile ducts. Among non-amyloidogenic immunoglobulin chain diseases, light-chain deposit disease can involve the liver. The liver is in fact the most frequent extrarenal localization of this disorder and is characterized by the deposition of granular or ribbonlike non-congophilic material along sinusoids.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agaram N, Shia J, Klimstra DS, Lau N, Lin O, Erlandson RA, Filippa DA, Godwin TA (2005) Globular hepatic amyloid: a diagnostic peculiarity that bears clinical significance. Hum Pathol 36:845–849
Bedossa P, Fabre M, Paraf F, Martin E, Lemaigre G (1988) Light chain deposition disease with liver dysfunction. Hum Pathol 19:1008–1014
Berrios M, Armas-Merino R, Franco C, Parrochia E, Wolff C (2003) Acute liver failure in patient with liver amyloidosis associated to multiple myeloma (in Spanish). Rev Med Chil 131:1301–1303
Buck FS, Koss MN (1991) Hepatic amyloidosis: morphologic differences between systemic AL and AA types. Hum Pathol 22:904–907
Buxbaum J, Gallo G (1999) Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light-and heavy-chain deposition diseases. Hematol Oncol Clin N Am 13:1235–1248
Buxbaum JN, Chuba JV, Hellman GC, Solomon A, Gallo GR (1990) Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition disease and their relation to light chain amyloidosis. Ann Intern Med 112:455–464
Case records of the Massachusetts General Hospital (case 1 – 1981) (1981) N Engl J Med 304:33
Casiraghi MA, De Paoli A, Assi A, Palladini G, Lavazza MT, Beretta A, Gualdoni G, Beretta R (2000) Hepatic amyloidosis with light chain deposition disease. A rare association. Dig Liver Dis 32:795–798
Chopra S, Rubinow A, Koff RS, Cohen AS (1984) Hepatic amyloidosis. A histopathologic analysis of primary (AL) and secondary (AA) forms. Am J Pathol 115:186–193
Cohen AS, Calkins E (1959) Electron microscopic observations on a fibrous component in amyloid of diverse origins. Nature 183:1202–1203
Cohen AD, Zhou P, Xiao Q, Fleisher M, Kalakonda N, Akhurst T, Chitale DA, Moscowitz C et al (2004) Systemic AL amyloidosis due to non-Hodgkin’s lymphoma: an unusual clinicopathologic association. Br J Haematol 124:309–314
Copeland JN, Kouides PA, Grieff M, Nadasdy T (2003) Metachronous development of nonamyloidogenic l light chain deposition disease and IgG heavy chain amyloidosis in the same patient. Am J Surg Pathol 27:1477–1482
Cosme A, Horcajada JP, Vidaur F, Ojeda E, Torrado J, Areans JI (1995) Systemic AA amyloidosis induced by oral contraceptive-associated hepatocellular adenoma: a 13-year follow up. Liver 15:164–167
Croitoru AG, Hytiroglou P, Schwartz ME, Saxena R (2006) Liver transplantation for liver rupture due to light chain deposition disease: a case report. Semin Liver Dis 26:298–303
Cross TJ, Wendon JA, Quaglia A, Salisbury JR, Heneghan MA, Harrison PM (2006) Myeloma associated amyloidosis presenting as subacute liver failure. Postgrad Med J 82:e13
Delgado MA, Liu JY, Meleg-Smith S (1999) Systemic amyloidosis associated with hepatocellular carcinoma. Case report and literature review. J La State Med Soc 151:474–478
Dickson JR, Harth M, Bell DA, Komar R, Chodirker WB (1989) Gamma heavy chain disease and rheumatoid arthritis. Semin Arthritis Rheum 18:247–251
Divry P, Florkin M (1927) Sur les propriétés optiques de l’amyloide. CR Soc Biol (Paris) 97:1808–1810
Dohmen K, Nagano M, Iwakiri R, Yamano Y, Kikuchi Y, Mizoguchi M, Iwata Y, Mori Y, Ishibashi H (1991) A case of prominent hepatic cholestasis developing to hepatic failure in lambda-AL amyloidosis. Gastroenterol Jpn 26:376–381
Droz D, Noel LH, Carnot F, Degos F, Ganeval D, Grunfeld JP (1984) Liver involvement in nonamyloid light chain deposit disease. Lab Invest 50:683–689
Econimo L, Jeannin G, Biasi L, Mazzola G, Mendeni M, Presteni K, Gregorini G (2011) Liver involvement with rapidly progressive course in light chain (AL) amyloidosis: distinguishing features at presentation. Experience of a single center. Amyloid 18(suppl a):109–111
Eulitz M, Weiss DT, Solomon A (1990) Immunoglobulin heavy-chain associated amyloidosis. Proc Natl Acad Sci U S A 87:6542–6546
Faa G, Van Eyken P, De Vos R, Fevery J, Van Damme B, De Groote J, Desmet VJ (1991) Light chain deposition disease of the liver associated with AL-type amyloidosis and severe cholestasis. J Hepatol 12:75–82
Ferreira S, Baldaia C, Fatela N, Ramalho F, Costa MA, Brito D, Esteves G, Monteiro E (2008) Severe intrahepatic cholestasis, erythrocytosis and hypoglycemia: unusual presenting features of systemic AL amyloidosis. Scand J Gastroenterol 43:375–379
Fievet P, Sevestre H, Boudjelal M, Noel LH, Kemeny F, Franco D, Delamarre J, Capron JP (1990) Systemic AA amyloidosis induced by liver cell adenoma. Gut 31:361–363
Frangione B, Franklin EC (1973) Heavy chain diseases: clinical features and molecular significance of the disordered immunoglobulin structure. Semin Hematol 10:54–64
French SW, Schloss GT, Stillman AE (1981) Unusual amyloid bodies in human liver. Am J Clin Pathol 75:400–402
Ganeval D, Noel LH, Droz D, Leibowitch J (1981) Systemic lambda light- chain deposition in a patient with myeloma. Br Med J 282:681–683
Ganeval D, Mignon F, Preud’homme JL, Noel LH, Morel-Maroger L, Droz D, Brouet JC et al (1982) Visceral deposition of monoclonal light chains and immunoglobulins: a study of renal and immunopathologic abnormalities. Adv Nephrol 11:25–63
Gertz MA, Kyle RA (1988) hepatic amyloidosis (primary [AL], immunoglobulin light chain): the natural history in 80 patients. Am J Med 85:73–80
Gertz MA, Kyle RA, Noel P (1993) Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and Waldenström’s macroglobulinemia. J Clin Oncol 11:914–920
Gioeva Z, Kieninger B, Röcken C (2009) Amyloidosis in liver biopsies (in German). Pathologe 30:240–245
Girelli C, Giovanni L, Rocca F (1998) Light chain deposition disease of the liver. Eur J Gastroenterol Hepatol 10:429–430
Glenner GG (1980) Amyloid deposits and amyloidosis. The betafibrilloses (first of two parts). N Engl J Med 302:1283–1292
Gono T, Yazaki M, Fushimi T, Suzuki T, Uehara T, Sano K, Kametani F, Ito N, Matsushita M et al (2006) AH amyloidosis associated with lymphoplasmacytic lymphoma secreting a monoclonal gamma heavy chain carrying an unusual truncated D segment. Am J Kidney Dis 47:908–914
Hall CL, Peat DS (2001) The interesting case light chain deposit disease: a frequent cause of diagnostic difficulty. Nephrol Dial Transplant 16:1939–1941
Harrison RF, Hawkins PN, Roche WR, MacMahon RF, Hubscher SG, Buckels JA (1996) ‘Fragile’ liver and massive hepatic hemorrhage due to hereditary amyloidosis. Gut 38:151–152
Hemmer PR, Topazian MD, Gertz MA, Abraham SC (2007) Globular amyloid deposits isolated to the small bowel: a rare association with AL amyloidosis. Am J Surg Pathol 31:141–145
Hoffman-guilaine C, Nochy D, Tricottet V, Mallet L, Bariety J, Camilleri JP (1984) La maladie des dépots de chaines légères: une entité anatomopathologique. Ann Pathol 4:105–113
Hoffman MS, Stein BE, Davidian MM, Rosenthal WS (1988) Hepatic amyloidosis presenting as severe intrahepatic cholestasis: a case report and review of the literature. Am J Gastroenterol 83:783–785
Husby G (1983) Immunoglobulin-related (AL) amyloidosis. Clin Exp Rheumatol 1:353–358
Hydes TJ, Aspinall RJ (2012) Subacute liver failure secondary to amyloid light-chain amyloidosis. Gastroenterol Hepatol 8:205–208
Iwamura S, Enzan H, Saibara T, Onishi S, Yamamoto Y (1995) Hepatic sinusoidal endothelial cells can store and metabolize serum immunoglobulin. Hepatology 22:1456–1461
Iwata T, Hoshii Y, Kawano H, Gondo T, Takahashi M, Ishihara T, Yokota T, Ueta J, Uchino F (1995) Hepatic amyloidosis in Japan: histological and morphometric analysis based on amyloid proteins. Hum Pathol 26:1148–1153
Jimenez-Zepeda VH (2012) Light chain deposition disease: novel biological insights and treatment advances. Int J Lab Hematol 34:347–355
Kambham N, Markowitz GS, Appel GB, Kleiner MJ, Aucouturier P, D’Agati VD (1999) Heavy chain deposition disease: the disease spectrum. Am J Kidney Dis 33:954–962
Kanel GC, Uchida T, Peters RL (1981) Globular hepatic amyloid – an unusual morphologic presentation. Hepatology 1:647–652
Katz A, Zent R, Bargman JM (1994) IgG heavy-chain deposition disease. Mod Pathol 7:874–878
Kebbel A, Röcken C (2006) Immunohistochemical classification of amyloid in surgical pathology revisited. Am J Surg Pathol 30:673–683
Kijner CH, Yousem SA (1988) Systemic light chain deposition disease presenting as multiple pulmonary nodules: a case report an review of the literature. Am J Surg Pathol 12:405–413
Kirkpatrick CJ, Curry A, Galle J, Melzner I (1986) Systemic kappa light chain deposition and amyloidosis in multiple myeloma: novel morphological observations. Histopathology 10:1065–1076
Kiyama M, Hoshii Y, Cui D, Kawano H, Kanda T, Ishihara T (2007) Immunohistochemical and immunochemical study of amyloid in liver affected by systemic Alambda amyloidosis with antibodies against three different regions of immunoglobulin lambda light chain. Pathol Int 57:343–350
Klinkenberg N, Reis HE, Rakow L (1991) Liver involvement as leading symptom of a kappa light-chain deposit disease (in German). Med Klin (Munich) 86:394–398
Konikoff F, Mor C, Stern S, Shaklai M, Halevy J, Theodor E (1987) Cholestasis and liver failure with lambda-AL amyloidosis. Gut 28:903–906
Kuçi H, Ebert MP, Röcken C (2007) Anti-lambda-light chain-peptide antibodies are suitable for the immunohistochemical classification of AL amyloid. Histol Histopathol 22:379–387
Kumar PN, Sandhya V, Venkatakrishnan L, Krishnaveni J, Mohanakrishnan A, Nirmala V (2012) Light chain deposition disease presenting as cholestatic jaundice: a case report. Oman Med J 27:56–59
Kwon AH, Tsuji K, Yamada H, Okazaki K, Sakaida N (2007) Amyloidosis of the gallbladder mimicking gallbladder cancer. J Gastroenterol 42:261–264
Kwon JH, Jeong SH, Kim JW, Bang SM, Kim H, Kim YH, Song SH (2011) Case report: a case of light chain deposition disease involving liver and stomach with chronic hepatitis C virus infection and hepatocellular carcinoma. J Med Virol 83:810–814
Kyle RA (2001) Historical review. Amyloidosis: a convoluted story. Br J Haematol 114:529–538
Le Verger JC, Toulet R, Deugnier Y, Ramie MP (1985) Anomalies biologiques hépatiques au cours d’une maladie de chaines légères. Gastroenterol Clin Biol 9:184–185
Levitan N, Rubinow A, Bromer RH, Conlon CL, Doos WG, Hong WK (1985) Transformation of lymphoma to amyloidoma following radiation therapy. Hum Pathol 16:1072–1074
Linardaki G, Drivas G, Archimandritis A (1997) AL-type amyloidosis presenting with rapidly deteriorating liver involvement. J Clin Gastroenterol 24:297–298
Linder J, Croker BP, Vollmer RT, Shelburne J (1983) Systemic kappa light-chain deposition. An ultrastructural and immunohistochemical study. Am J Surg Pathol 7:85–93
Looi LM, Sumithran E (1988) Morphologic differences in the pattern of liver infiltration between systemic AL and AA amyloidosis. Hum Pathol 19:732–735
Lovat LB, Persey MR, Madhoo S, Pepys MB, Hawkins PN (1998) The liver in systemic amyloidosis: insights from 1231 serum amyloid P component scintigraphy in 484 patients. Gut 42:727–734
Macias Robles MD, Navia-Osorio Garcia-Braga JM, Menendez Caro JL, Velasco Alonso J, Lopez Lagunas I (1994) Jaundice secondary to intrahepatic deposit of light chains as a presenting form of multiple myeloma (in Spanish). An Med Interna 11:74–76
Mai HL, Sheikh-Hamad D, Herrera GA, Gu X, Truong LD (2003) Immunoglobulin heavy chain can be amyloidogenic: morphologic characterization including immunoelectron microscopy. Am J Surg Pathol 27:541–545
Mainenti PP, Petrelli G, Lamanda R, Amalfi G, Castiglione F (1997) Primary systemic amyloidosis with giant hepatomegaly and a swiftly progressive course. J Clin Gastroenterol 24:173–175
Makhlouf HR, Goodman ZD (2007) Globular hepatic amyloid: an early stage in the pathway of amyloid formation: a study of 20 new cases. Am J Surg Pathol 31:1615–1621
Maniatis A (1998) Pathophysiology of paraprotein production. Ren Fail 20:821–828
Masai R, Wakui H, Togashi M, Maki N, Ohtani H, Komatsuda A, Sawada K (2009) Clinicopathological features and prognosis in immunoglobulin light and heavy chain deposition disease. Clin Nephrol 71:9–20
Melin JP, Lecrique T, Wynckel A, Wong T, Noel LH, Belghiti J, Chanard J (1993) Remission of nephrotic syndrome related to AA amyloidosis after hepatic adenomectomy. Nephron 64:157–158
Mena-Duran A, Muñoz VE, Pareja LG, Sanchis CJ (2012) Liver failure caused by light chain deposition disease associated with multiple myeloma. Intern Med 51:773–776
Merlini G, Bellotti V (2003) Molecular mechanisms of amyloidosis. N Engl J Med 349:583–596
Michopoulos S, Petraki K, Petraki C, Dimopulos MA (2002) Light chain deposition disease of the liver without renal involvement in a patient with multiple myeloma related to liver failure and rapid fatal outcome. Dig Dis Sci 47:730–734
Mignon F, Morel-Maroger L, Cerf M, Preud’homme JL, Richet G (1980) Hepatic and renal deposits of kappa light chains revealing a dysglobulinemia (in French). Nephrologie 1:167–170
Mohr A, Miehlke S, Klauck S, Röcken C, Malfertheimer P (1999) hepatomegaly and cholestasis as primary clinical manifestations of an AL-kappa amyloidosis. Eur J Gastroenterol Hepatol 11:921–925
Naito KS, Ichiyama T, Kawakami S, Kadoya M, Tabata T, Matsuda M, Ikeda S (2008) AL amyloidosis with spontaneous hepatic rupture: successful treatment by transcatheter hepatic artery embolization. Amyloid 15:137–139
Nath SV, Peiris M, Bishton MJ, Maxwell E, Prince HM (2010) Light chain deposition disease presenting as massive hepatomegaly. Pathology 42:307–310
Oe Y, Nakaya I, Yahata M, Sakuma T, Sato H, Soma J (2010) A case of g1-heavy chain deposition disease successfully treated with melphalan and prednisolone therapy. Intern Med 49:1411–1415
Okabe M, Choi GH, Kudo M, Nakaya H, Kishimoto A, Suzuki H, Miyagishima T (1998) Hepatic failure due to myeloma-associated amyloidosis. J Gastroenterol 33:926–927
Okura T, Miyoshi K, Nagao T, Jotoku M, Enomoto D, Irita J, Kurata M, Higaki J (2009) Light chain deposition disease developing 15 years following the diagnosis of monoclonal gammopathy of undetermined significance. Intern Med 48:101–104
Park MA, Mueller PS, Kyle RA, Larson DR, Plevak MF, Gertz MA (2003) Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients. Medicine (Baltimore) 82:291–298
Paudice N, Farsetti S, Caroti L, Ciuti G, Tempestini A, Perfetto F, Bergesio F (2011) Severe recurrent intrahepatic cholestasis in systemic AL amyloidosis without evident liver involvement. Unexplained hepatic toxicity or a case of misdiagnosed liver amyloidosis? Amyloid 18(suppl 1):142–144
Pelletier G, Fabre M, Attali P, Ladouch-Badre A, Ink O, Martin E, Etienne JP (1988) Light chain deposition disease presenting with hepatomegaly: an association with amyloid-like fibrils. Postgrad Med J 64:804–808
Piard F, Yaziji N, Jarry O, Assem M, Martin L, Bernard A, Jacquot JP, Justrabo E (1998) Solitary plasmacytoma of the lung with light chain extracellular deposits: a case report and review of the literature. Histopathology 32:356–361
Pilgaard J, Fenger C, Schaffalitzky de Muckadell OB (1993) Globular amyloid deposits in the liver. Histopathology 23:479–480
Pinney JH, Hawkins PN (2012) Amyloidosis. Ann Clin Biochem 49:229–241
Pozzi C, Locatelli F (2002) Kidney and liver involvement in monoclonal light chain disorders. Semin Nephrol 22:319–330
Pozzi C, Fogazzi GB, Banfi G, Strom EH, Ponticelli C, Locatelli F (1995) Renal disease and patient survival in light chain deposit disease. Clin Nephrol 43:281–287
Preud’homme JL, Morel-Maroger L, Brouet JC, Cerf M, Mignon F, Guglielmi P, Seligmann M (1980) Synthesis of abnormal immunoglobulins in lymphoplasmacytic disorders with visceral light chain deposition. Am J Med 69:703–710
Ramirez-Alvarado M (2012) Amyloid formation in light chain amyloidosis. Curr Top Med Chem 12:2523–2533
Randall RE, Williamson WC, Mullinax F, Tung MY, Still WJS (1976) Manifestations of systemic light chain deposition. Am J Med 60:293–299
Remy AJ, Perney P, Bourat L, Ramos J, Marty M, Cabaniols H, Durand L, Quenet F, Blanc F (1995) Amyloidosis of the gallbladder. An unusual localization (in French). Gastroenterol Clin Biol 19:215–217
Reuben A (2004) The legend of the lardaceous liver. Hepatology 40:763–766
Ronco P, Plaisier E, Aucouturier P (2011) Monoclonal immunoglobulin light and heavy chain deposition diseases: molecular models of common renal diseases. Contrib Nephrol 169:221–231
Rosen DJ, Stavropoulos C, Travis WD, Ashton RC, Bhora FY, Connery CP (2008) Transdiaphragmatic amyloidoma. Ann Thorac Surg 86:310–312
Rostagno A, Frizzera G, Ylagan L, Kumar A, Ghiso J, Gallo G (2002) Tumoral non-amyloidotic monoclonal immunoglobulin light chain deposits (‘aggregoma’): presenting feature of B-cell dyscrasia in three cases with immunohistochemical and biochemical analyses. Br J Haematol 119:62–69
Rubinow A, Koff RS, Cohen AS (1978) Severe intrahepatic cholestasis in primary amyloidosis: a report of four cases and a review of the literature. Am J Med 64:937–946
Ryan RJ, Sloan JM, Collins AB, Mansouri J, Raje NS, Zukerberg LR, Ferry JA (2012) Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with amyloid deposition: a clinicopathologic case series. Am J Clin Pathol 137:51–64
Samanez C, Domingo A, Cibeira MT, Miquel R, Soler M, Bladé J (2006) Development of rapidly progressive liver light chain deposition under VAD chemotherapy in multiple myeloma. Eur J Haematol 76:83–85
Sarsik B, Sen S, Kirdok FS, Akarca US, Toz H, Yilmaz F (2012) Hepatic amyloidosis: morphologic spectrum of histopathological changes in AA and nonAA amyloidosis. Pathol Res Pract 208:713–718
Sasaki M, Nakanuma Y, Terada T, Hoso M, Saito K, Hayashi M, Kurumaya H (1990) Amyloid deposition in intrahepatic large bile ducts and peribiliary glands in systemic amyloidosis. Hepatology 12:743–746
Satani T, Yokose T, Kaburagi T, Asato Y, Itabashi M, Amemiya R (2007) Amyloid deposition in primary pulmonary marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Pathol Int 57:746–750
Schmid PA, Burger HR, Spycher MA, Bühler H, Heitz PU (1992) Primary amyloidosis of the liver (in German). Dtsch Med Wochenschr 117:1014–1018
Shibasaki T, Matsumoto H, Watabe K, Joh K, Nakano H, Matsuda H, Gomi H, Ohno I, Ishimoto F, Sakai O (1997) A case of renal amyloidosis associated with hepatic adenoma: the pathogenetic role of tumor necrosis factor-alpha. Nephron 75:350–353
Simmonds PD, Cottrell BJ, Mead GM, Wright DH, Whitehouse JM (1997) Lymphadenopathy due to amyloid deposition in non-Hodgkin’s lymphoma. Ann Oncol 8:267–270
Smith NM, Malcolm AJ (1986) Simultaneous AL-type amyloid and light chain deposit disease in a liver biopsy: a case report. Histopathology 10:1057–1064
Soma J, Sato K, Sakuma T, Saito H, Sato H, Sato T, Abbas A, Aucouturier P (2004) Immunoglobulin gamma3-heavy-chain deposition disease: report of a case and relationship with hypocomplementemia. Am J Kidney Dis 43:E10–E16
Son RC, Chang JC, Choi JH (2011a) Primary hepatic amyloidosis: report of an unusual case presenting as a mass. Korean J Radiol 12:382–385
Son YM, Choi JY, Bak CH, Cheon M, Kim YE, Lee KH, Kim BT (2011b) 18F-FDG PET/CT in primary AL hepatic amyloidosis associated with multiple myeloma. Korean J Radiol 12:634–637
Stokes MB, Jagirdar J, Burchstin O, Kornacki S, Kumar A, Gallo G (1997) Nodular pulmonary immunoglobulin light chain deposits with coexistent amyloid and nonamyloid features in an HIV-infected patient. Mod Pathol 10:1059–1065
Szturz P, Kyclova J, Moulis M, Navratil M, Adam Z, Vanicek J, Mayer J (2013) Extensive AL amyloidosis presenting with recurrent liver hemorrhage and hemoperitoneum: case report and literature review. Klin Onkol 26:49–52
Tabata S, Kurata M, Takeda J, Funayama Y, Yamauchi N, Aoki K, Kato A, Ono Y et al (2012) Fatal hepatic failure due to AL amyloidosis in a patient with multiple myeloma. Rinsho Ketsueki 53:1906–1910
Tam M, Seldin DC, Forbes BM, Connors LH, Skinner M, Oran B, Quillen K, Sanchorawala V (2009) Spontaneous rupture of the liver in a patient with systemic AL amyloidosis undergoing treatment with high-dose melphalan and autologous stem cell transplantation: a case report with literature review. Amyloid 16:103–107
Terada T, Hirata K, Hisada Y, Hoshii Y, Nakanuma Y (1994) Obstructive jaundice caused by the deposition of amyloid-like substances in the extrahepatic and large intrahepatic bile ducts in a patient with multiple myeloma. Histopathology 24:485–487
Thysell H, Ingvar C, Gustafson T, Holmin T (1986) Systemic reactive amyloidosis caused by hepatocellular adenoma. A case report. J Hepatol 2:450–457
Tötterman KJ, Manninen V (1982) Tumefactive liver infiltration in amyloidosis. Ann Clin Res 14:11–14
Toyoda M, Kajita A, Kita S, Osamura Y, Shinoda T (1988) An autopsy case of diffuse myelomatosis associated with systemic kappa light chain deposition disease (LCDD). A patho-anatomical, immunohistochemical and immunobiological study. Acta Pathol Jpn 38:479–488
Tschang TP (1976) Nodular malignant lymphoma and amyloidosis. A case report. Cancer 38:2192–2196
Varela M, De Las Heras D, Miguel R (2003) Hepatic failure due to primary AL amyloidosis. J Hepatol 39:290
Vidal R, Goni F, Stevens F, Aucouturier P, Kumar A, Frangione B, Ghiso J et al. (1999) Somatic mutations of the LRA gene in V-kl light chain deposition disease. Potential effects on aberrant protein conformation and deposition. Am J Pathol 155:2009–2017
Wang YD, Zhao CY, Yin HZ (2012) Primary hepatic amyloidosis: a mini literature review and five cases report. Ann Hepatol 11:721–727
Weisel KC, Böckeler M, Bianchi L, Terracciano LM, Mayer F, Kanz L (2009) Development of rapid light-chain deposition disease in hepatic arteries with severe ischemic cholangitis in a multiple myeloma patient treated with melphalan, prednisone and lenalidomide. Int J Hematol 89:91–94
Westermark P (2012) Localized AL amyloidosis: a suicidal neoplasm? Upsala J Med Sci 117:244–250
Yamamoto T, Maeda N, Kawasaki H (1995) Hepatic failure in a case of multiple myeloma-associated amyloidosis (kappa-AL). J Gastroenterol 30:393–397
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this entry
Cite this entry
Zimmermann, A. (2017). Amyloidogenic Immunoglobulin Chain and Non-amyloidogenic Immunoglobulin Chain Diseases. In: Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Springer, Cham. https://doi.org/10.1007/978-3-319-26956-6_93
Download citation
DOI: https://doi.org/10.1007/978-3-319-26956-6_93
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-26954-2
Online ISBN: 978-3-319-26956-6
eBook Packages: MedicineReference Module Medicine